Skip to main content
SpringerLink
Log in

The pattern of gray matter atrophy in Parkinson’s disease differs in cortical and subcortical regions

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Cortical and subcortical gray matter (GM) atrophy may progress differently during the course of Parkinson’s disease (PD). We delineated and compared the longitudinal pattern of these PD-related changes. Structural MRIs and clinical measures were obtained from 76 PD with different disease durations and 70 Controls at baseline, 18-, and 36 months. Both cortical and subcortical (putamen, caudate, and globus pallidus) GM volumes were obtained, compared, and associated with PD clinical measures at baseline. Their volumes and rates of change also were compared among Controls, PDs, and PD subgroups based on duration of illness [≤1 year (PDE), 1–5 years (PDM), and >5 years (PDL)]. Compared to Controls, PD subjects displayed smaller cortical GM and striatal (putamen, caudate, ps ≤0.001), volumes at baseline. Cortical GM volumes were negatively associated with disease duration at baseline, whereas striatal volumes were not. PD subjects demonstrated accelerated volume loss in cortical GM (p = 0.006), putamen (p = 0.034), and caudate (p = 0.008) compared to Controls. Subgroup analyses demonstrated that accelerated cortical atrophy reached statistical significance in PD subjects with duration of illness 1–5 years (PDM, ps <0.001) and the trend of accelerated atrophy seemed to persist until later stages, whereas striatal atrophy occurred in PD subjects with PDE (p = 0.021 for putamen, p = 0.005 for caudate) and PDM (p = 0.002 for putamen, p = 0.001 for caudate) that significantly slowed down in PDL (ps for PDL vs PDE or PDM: <0.01). The pattern of GM loss in PD differs in cortical and subcortical regions, with striatal atrophy occurring earlier and extra-striatal cortical atrophy later.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Braak H, Del Tredici K, Rub U, de Vos RA, Steur ENJ, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211

    Article  PubMed  Google Scholar 

  2. Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ et al (2012) Grey matter atrophy in cognitively impaired Parkinson’s disease. J Neurol Neurosurg Psychiatry 83(2):188–194

    Article  PubMed  Google Scholar 

  3. Martin WR, Wieler M, Gee M, Camicioli R (2009) Temporal lobe changes in early, untreated Parkinson’s disease. Mov Disord 24(13):1949–1954

    Article  PubMed  Google Scholar 

  4. Gerrits NJ, van der Werf YD, Hofman M, Foncke EM, Klein M, Berendse HW et al (2014) Gray matter differences contribute to variation in cognitive performance in Parkinson’s disease. Eur J Neurol 21(2):245–252

    Article  CAS  PubMed  Google Scholar 

  5. Hu MT, White SJ, Chaudhuri KR, Morris RG, Bydder GM, Brooks DJ (2001) Correlating rates of cerebral atrophy in Parkinson’s disease with measures of cognitive decline. J Neural Transm 108(5):571–580

    Article  CAS  PubMed  Google Scholar 

  6. Ibarretxe-Bilbao N, Junque C, Segura B, Baggio HC, Marti MJ, Valldeoriola F et al (2012) Progression of cortical thinning in early Parkinson’s disease. Mov Disord 27(14):1746–1753

    Article  PubMed  Google Scholar 

  7. Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ et al (2015) Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study. Brain 138(Pt 10):2974–2986

    Article  PubMed Central  PubMed  Google Scholar 

  8. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC (2006) Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 129(Pt 4):1040–1049

    Article  PubMed  Google Scholar 

  9. Camicioli R, Sabino J, Gee M, Bouchard T, Fisher N, Hanstock C et al (2011) Ventricular dilatation and brain atrophy in patients with Parkinson’s disease with incipient dementia. Mov Disord 26(8):1443–1450

    Article  PubMed  Google Scholar 

  10. Fearnley JM, Lees AJ (1991) Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 114(Pt 5):2283–2301

    Article  PubMed  Google Scholar 

  11. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20(4):415–455

    Article  CAS  PubMed  Google Scholar 

  12. Schulzer M, Lee CS, Mak EK, Vingerhoets FJ, Calne DB (1994) A mathematical model of pathogenesis in idiopathic parkinsonism. Brain 117(Pt 3):509–516

    Article  PubMed  Google Scholar 

  13. Halliday GM, McCann H (2010) The progression of pathology in Parkinson’s disease. Ann N Y Acad Sci 1184:188–195

    Article  PubMed  Google Scholar 

  14. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56(1):33–39

    Article  CAS  PubMed  Google Scholar 

  15. Doty RL, Shaman P, Dann M (1984) Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 32(3):489–502

    Article  CAS  PubMed  Google Scholar 

  16. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170

    Article  PubMed  Google Scholar 

  18. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T et al (1992) Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 7(1):2–13

    Article  CAS  PubMed  Google Scholar 

  19. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653

    Article  PubMed  Google Scholar 

  20. Ruigrok AN, Salimi-Khorshidi G, Lai MC, Baron-Cohen S, Lombardo MV, Tait RJ et al (2014) A meta-analysis of sex differences in human brain structure. Neurosci Biobehav Rev 39:34–50

    Article  PubMed Central  PubMed  Google Scholar 

  21. Du G, Lewis MM, Sen S, Wang J, Shaffer ML, Styner M et al (2012) Imaging nigral pathology and clinical progression in Parkinson’s disease. Mov Disord 27(13):1636–1643

    Article  PubMed Central  PubMed  Google Scholar 

  22. Rosenberg-Katz K, Herman T, Jacob Y, Giladi N, Hendler T, Hausdorff JM (2013) Gray matter atrophy distinguishes between Parkinson disease motor subtypes. Neurology 80(16):1476–1484

    Article  PubMed Central  PubMed  Google Scholar 

  23. Fioravanti V, Benuzzi F, Codeluppi L, Contardi S, Cavallieri F, Nichelli P et al (2015) MRI correlates of Parkinson’s disease progression: a voxel based morphometry study. Parkinsons Dis 2015:378032

    PubMed Central  PubMed  Google Scholar 

  24. Weintraub D, Dietz N, Duda JE, Wolk D, Doshi J, Xie SX et al (2012) Alzheimer’s disease pattern of brain atrophy predicts cognitive decline in Parkinson’s disease. Brain J Neurol 135(Pt 1):170–180

    Article  Google Scholar 

  25. Kato S, Watanabe H, Senda J, Hirayama M, Ito M, Atsuta N et al (2012) Widespread cortical and subcortical brain atrophy in Parkinson’s disease with excessive daytime sleepiness. J Neurol 259(2):318–326

    Article  CAS  PubMed  Google Scholar 

  26. Hanganu A, Bedetti C, Degroot C, Mejia-Constain B, Lafontaine AL, Soland V et al (2014) Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson’s disease longitudinally. Brain 137(Pt 4):1120–1129

    Article  PubMed  Google Scholar 

  27. Lee EY, Eslinger PJ, Du G, Kong L, Lewis MM, Huang X (2014) Olfactory-related cortical atrophy is associated with olfactory dysfunction in Parkinson’s disease. Mov Disord 29(9):1205–1208

    Article  PubMed Central  PubMed  Google Scholar 

  28. Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357–381

    Article  CAS  PubMed  Google Scholar 

  29. Peran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, et al (2010) Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature. Brain 33(11):3423–3433

    Article  Google Scholar 

  30. Middleton FA, Strick PL (2000) Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Brain Res Rev 31(2–3):236–250

    Article  CAS  PubMed  Google Scholar 

  31. Lee CS, Schulzer M, Mak EK, Snow BJ, Tsui JK, Calne S et al (1994) Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 117(Pt 3):501–507

    Article  PubMed  Google Scholar 

  32. Rossi C, Frosini D, Volterrani D, De FP, Unti E, Nicoletti V et al (2010) Differences in nigro-striatal impairment in clinical variants of early Parkinson’s disease: evidence from a FP-CIT SPECT study. Eur J Neurol 17(4):626–630

    Article  CAS  PubMed  Google Scholar 

  33. Maetzler W, Liepelt I, Berg D (2009) Progression of Parkinson’s disease in the clinical phase: potential markers. Lancet Neurol 8(12):1158–1171

    Article  CAS  PubMed  Google Scholar 

  34. Perlmutter JS, Norris SA (2014) Neuroimaging biomarkers for Parkinson disease: facts and fantasy. Ann Neurol 76(6):769–783

    Article  PubMed Central  PubMed  Google Scholar 

  35. Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, Montastruc JL (2003) Limitations of current Parkinson’s disease therapy. Ann Neurol 53(Suppl 3):S3–S12

    Article  CAS  PubMed  Google Scholar 

  36. Lee CS, Schulzer M, Mak EK, Snow BJ, Tsui JK, Calne S et al (1994) Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 117(Pt 3):501–507

    Article  PubMed  Google Scholar 

  37. Lee CS, Schulzer M, Fuente-Fernandez R, Mak E, Kuramoto L, Sossi V et al (2004) Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis. Arch Neurol 61(12):1920–1925

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We express gratitude to all of the participants who volunteered for this study and study personnel who contributed to its success. This work was supported in part by the National Institute of Neurological Disease and Stroke (NS060722 and NS082151 to XH), the Hershey Medical Center General Clinical Research Center (National Center for Research Resources, Grant UL1 RR033184 that is now at the National Center for Advancing Translational Sciences, Grant UL1 TR000127), and the PA Department of Health Tobacco CURE Funds. All analyses, interpretations, and conclusions are those of the authors and not the research sponsors.

Author information

Author notes

    Authors and Affiliations

    1. Department of Neurology, Pennsylvania State University, H037, 500 University Drive, Hershey, PA, 17033-0850, USA

      Mechelle M. Lewis, Guangwei Du, Eun-Young Lee, Zeinab Nasralah, Nicholas W. Sterling, Lijun Zhang, Daymond Wagner, Paul J. Eslinger, Richard B. Mailman & Xuemei Huang

    2. Department of Pharmacology, Pennsylvania State University, Hershey, PA, 17033, USA

      Mechelle M. Lewis, Richard B. Mailman & Xuemei Huang

    3. Department of Public Health Sciences, Pennsylvania State University, Hershey, PA, 17033, USA

      Lan Kong

    4. Department of Clinical Neuropsychology, The Barrow Neurological Institute, Phoenix, AZ, 85013, USA

      Alexander I. Tröster

    5. Department of Psychiatry, UNC, Chapel Hill, NC, 27599, USA

      Martin Styner

    6. Department of Computer Science, UNC, Chapel Hill, NC, 27599, USA

      Martin Styner

    Authors
    1. Mechelle M. Lewis
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Guangwei Du
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Eun-Young Lee
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Zeinab Nasralah
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Nicholas W. Sterling
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Lijun Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Daymond Wagner
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Lan Kong
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Alexander I. Tröster
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Martin Styner
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. Paul J. Eslinger
      View author publications

      You can also search for this author in PubMed Google Scholar

    12. Richard B. Mailman
      View author publications

      You can also search for this author in PubMed Google Scholar

    13. Xuemei Huang
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Xuemei Huang.

    Ethics declarations

    Conflicts of interest

    The authors declare that they have no conflict of interest.

    Ethical standards

    The study was approved by the Penn State Hershey Institutional Review Board and conducted in accordance with the principles of the Declaration of Helsinki. All subjects gave their informed consent prior to their inclusion in the study.

    Additional information

    M. M. Lewis and G. Du contributed equally to this work.

    Electronic supplementary material

    Below is the link to the electronic supplementary material.

    415_2015_7929_MOESM1_ESM.tif

    Supplementary material 1: Annual rates of change in PD subjects were plotted based on disease duration for each region of interest. The solid black line in each graph represents the rolling average and the shaded areas the confidence intervals (TIFF 1046 kb)

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Lewis, M.M., Du, G., Lee, EY. et al. The pattern of gray matter atrophy in Parkinson’s disease differs in cortical and subcortical regions. J Neurol 263, 68–75 (2016). https://doi.org/10.1007/s00415-015-7929-7

    Download citation

    • Received:

    • Revised:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00415-015-7929-7

    Keywords

    Search

    Navigation